280 related articles for article (PubMed ID: 34023508)
21. Sustainable Tumor-Suppressive Effect of iPSC-Derived Rejuvenated T Cells Targeting Cervical Cancers.
Honda T; Ando M; Ando J; Ishii M; Sakiyama Y; Ohara K; Toyota T; Ohtaka M; Masuda A; Terao Y; Nakanishi M; Nakauchi H; Komatsu N
Mol Ther; 2020 Nov; 28(11):2394-2405. PubMed ID: 32710827
[TBL] [Abstract][Full Text] [Related]
22. The Generation of Human γδT Cell-Derived Induced Pluripotent Stem Cells from Whole Peripheral Blood Mononuclear Cell Culture.
Watanabe D; Koyanagi-Aoi M; Taniguchi-Ikeda M; Yoshida Y; Azuma T; Aoi T
Stem Cells Transl Med; 2018 Jan; 7(1):34-44. PubMed ID: 29164800
[TBL] [Abstract][Full Text] [Related]
23. In Vitro Differentiation of T Cells from Murine Pluripotent Stem Cells.
Chen X; Lei F; Wang L; Xiong X; Song J
Methods Mol Biol; 2019; 2048():131-141. PubMed ID: 31396937
[TBL] [Abstract][Full Text] [Related]
24. In vitro methods for generating CD8+ T-cell clones for immunotherapy from the naïve repertoire.
Ho WY; Nguyen HN; Wolfl M; Kuball J; Greenberg PD
J Immunol Methods; 2006 Mar; 310(1-2):40-52. PubMed ID: 16469329
[TBL] [Abstract][Full Text] [Related]
25. An Improved Method to Produce Clinical-Scale Natural Killer Cells from Human Pluripotent Stem Cells.
Zhu H; Kaufman DS
Methods Mol Biol; 2019; 2048():107-119. PubMed ID: 31396935
[TBL] [Abstract][Full Text] [Related]
26. Generation of cDC-like cells from human induced pluripotent stem cells via Notch signaling.
Makino K; Long MD; Kajihara R; Matsueda S; Oba T; Kanehira K; Liu S; Ito F
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35101945
[TBL] [Abstract][Full Text] [Related]
27. Induced Pluripotent Stem Cell (iPSC)-Derived Lymphocytes for Adoptive Cell Immunotherapy: Recent Advances and Challenges.
Nianias A; Themeli M
Curr Hematol Malig Rep; 2019 Aug; 14(4):261-268. PubMed ID: 31243643
[TBL] [Abstract][Full Text] [Related]
28. Melanoma Immunotherapy in Mice Using Genetically Engineered Pluripotent Stem Cells.
Haque M; Song J; Fino K; Sandhu P; Wang Y; Ni B; Fang D; Song J
Cell Transplant; 2016; 25(5):811-27. PubMed ID: 26777320
[TBL] [Abstract][Full Text] [Related]
29. [iPSC-derived rejuvenated T-cell therapy for Epstein-Barr virus-associated lymphomas].
Ando M; Nakauchi H; Komatsu N
Rinsho Ketsueki; 2018; 59(7):932-938. PubMed ID: 30078805
[TBL] [Abstract][Full Text] [Related]
30. Non-clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell-derived anti-glypican-3 chimeric antigen receptor-expressing natural killer/innate lymphoid cells.
Ueda T; Kumagai A; Iriguchi S; Yasui Y; Miyasaka T; Nakagoshi K; Nakane K; Saito K; Takahashi M; Sasaki A; Yoshida S; Takasu N; Seno H; Uemura Y; Tamada K; Nakatsura T; Kaneko S
Cancer Sci; 2020 May; 111(5):1478-1490. PubMed ID: 32133731
[TBL] [Abstract][Full Text] [Related]
31. Clinical-Grade Human Multipotent Adult Progenitor Cells Block CD8+ Cytotoxic T Lymphocytes.
Plessers J; Dekimpe E; Van Woensel M; Roobrouck VD; Bullens DM; Pinxteren J; Verfaillie CM; Van Gool SW
Stem Cells Transl Med; 2016 Dec; 5(12):1607-1619. PubMed ID: 27465071
[TBL] [Abstract][Full Text] [Related]
32. Clinical-scale derivation of natural killer cells from human pluripotent stem cells for cancer therapy.
Knorr DA; Ni Z; Hermanson D; Hexum MK; Bendzick L; Cooper LJ; Lee DA; Kaufman DS
Stem Cells Transl Med; 2013 Apr; 2(4):274-83. PubMed ID: 23515118
[TBL] [Abstract][Full Text] [Related]
33. In vitro stimulation and expansion of human tumour-reactive CD8+ cytotoxic T lymphocytes by anti-CD3/CD28/CD137 magnetic beads.
Teschner D; Wenzel G; Distler E; Schnürer E; Theobald M; Neurauter AA; Schjetne K; Herr W
Scand J Immunol; 2011 Aug; 74(2):155-64. PubMed ID: 21517928
[TBL] [Abstract][Full Text] [Related]
34. Reprogramming away from the exhausted T cell state.
Karagiannis P; Iriguchi S; Kaneko S
Semin Immunol; 2016 Feb; 28(1):35-44. PubMed ID: 26589493
[TBL] [Abstract][Full Text] [Related]
35. Large-scale expansion of γδ T cells and peptide-specific cytotoxic T cells using zoledronate for adoptive immunotherapy.
Yoshikawa T; Takahara M; Tomiyama M; Nieda M; Maekawa R; Nakatsura T
Int J Oncol; 2014 Nov; 45(5):1847-56. PubMed ID: 25189159
[TBL] [Abstract][Full Text] [Related]
36. Differentiation of glioma and radiation injury in rats using in vitro produce magnetically labeled cytotoxic T-cells and MRI.
Arbab AS; Janic B; Jafari-Khouzani K; Iskander AS; Kumar S; Varma NR; Knight RA; Soltanian-Zadeh H; Brown SL; Frank JA
PLoS One; 2010 Feb; 5(2):e9365. PubMed ID: 20195476
[TBL] [Abstract][Full Text] [Related]
37. Stem Cell-Derived Viral Antigen-Specific T Cells Suppress HIV Replication and PD-1 Expression on CD4+ T Cells.
Haque M; Lei F; Xiong X; Ren Y; Peng HY; Wang L; Kumar A; Das JK; Song J
Viruses; 2021 Apr; 13(5):. PubMed ID: 33923025
[TBL] [Abstract][Full Text] [Related]
38. A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants.
Vizcardo R; Rafiqul Islam SM; Maeda T; Tamaoki N; Good ML; Klemen ND; Bosch-Marce M; Jia L; Kruhlak MJ; Restifo NP
J Vis Exp; 2019 Aug; (150):. PubMed ID: 31449236
[TBL] [Abstract][Full Text] [Related]
39. Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions.
Slamecka J; Salimova L; McClellan S; van Kelle M; Kehl D; Laurini J; Cinelli P; Owen L; Hoerstrup SP; Weber B
Cell Cycle; 2016; 15(2):234-49. PubMed ID: 26654216
[TBL] [Abstract][Full Text] [Related]
40. Soluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8
Hasan AN; Selvakumar A; Shabrova E; Liu XR; Afridi F; Heller G; Riviere I; Sadelain M; Dupont B; O'Reilly RJ
Clin Exp Immunol; 2016 Nov; 186(2):249-265. PubMed ID: 27227483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]